Medicine and Dentistry
Stromal Cell
100%
Krukenberg Tumor
100%
Neoplasm
96%
Very Late Activation Antigen 4
66%
Ovarian Cancer
58%
Vascular Cell Adhesion Molecule 1
54%
Very Late Activation Antigen 5
54%
Phase II Trials
50%
Therapeutic Vaccine
50%
Cervical Intraepithelial Neoplasia
50%
BRCA1
50%
BRCA2
50%
T Cell Subset
50%
Non Small Cell Lung Cancer
50%
Beta1 Integrin
50%
Hereditary Nonpolyposis Colorectal Cancer
50%
Cell Activation
50%
Fluorescence in Situ Hybridization
50%
Stroma
50%
Endothelial Cell
50%
Tumor Cell
50%
Reverse Transcription Polymerase Chain Reaction
50%
B Cell
50%
CD8 Antigen
38%
Cytoreductive Surgery
35%
Cell Interaction
33%
Fibronectin
33%
HL60
33%
Cell Adhesion Molecule
29%
Cell Contact
29%
In Vitro
29%
Intercellular Adhesion Molecule 1
25%
Cell Line
25%
Binding Affinity
25%
Erythroleukemia Cell
25%
Debulking Surgery
25%
Neoadjuvant Chemotherapy
25%
K562 Cells
20%
Bone Marrow Stromal Cell
20%
Visual Analog Scale
20%
Cytotoxic T-Cell
18%
Crizotinib
18%
Colposcopy
16%
T Cell
16%
Immunoglobulin A
16%
Chronic Myelogenous Leukemia
12%
Epileptic Absence
12%
Acute Leukemia
12%
Endothelial Leukocyte Adhesion Molecule 1
12%
Tumor Necrosis Factor
12%
Keyphrases
Stromal Cells
100%
Human Bone Marrow
100%
Immunization
71%
VLA-4
66%
Therapeutic Vaccine
66%
HPV16
58%
VLA-5
54%
Bone Marrow Stroma
50%
Cancer Vaccine
50%
First-in-human
50%
Tumor Cells
50%
Integrin β1
50%
High-risk Human Papillomavirus (HR-HPV)
50%
Phase I Clinical Trial
50%
Laser Dissection Microscopy
50%
Cell Trafficking
50%
Leukemic Cells
50%
RNA Replicon
50%
B Cells
50%
High-grade Serous Ovarian Cancer (HGSOC)
50%
High-grade Cervical Intraepithelial Neoplasia
50%
Phase II Trial
50%
Vascular Cell Adhesion molecule-1 (VCAM-1)
41%
K562
37%
Cervical Intraepithelial Neoplasia Grade 3
35%
Cell Interaction
33%
Fibronectin
33%
Cell Monolayer
33%
HL-60 Cells
33%
Adhesion Molecules
29%
Cell Contact
29%
Binding Affinity
25%
Erythroleukemia Cells
25%
Whole Section
25%
RNA Integrity
25%
Neoadjuvant Chemotherapy
25%
Semliki Forest Virus
23%
Infectious Particles
23%
Inhibition Studies
20%
Human Mesenchymal Stem Cells (hMSCs)
20%
Advanced Non-small Cell Lung Carcinoma
18%
CD4+
16%
Adhesion
16%
HPV16 E7
16%
Tumor
16%
Cell Status
16%
Primary Debulking Surgery
16%
Vaccine Response
15%
Incompetence
15%
Colposcopy
14%
Immunology and Microbiology
VCAM-1
66%
VLA-4
66%
Very Late Activation Antigen 5
54%
Cell Isolation
50%
Cancer Vaccine
50%
T Cell Subset
50%
Reverse Transcription Polymerase Chain Reaction
50%
Cell Activation
50%
Vaccine Efficacy
50%
Wart Virus
50%
CD8
50%
Cytotoxic T-Cell
50%
Replicon
50%
Tumor Cell
50%
Beta1 Integrin
50%
Stroma
50%
Intercellular Adhesion Molecule 1
37%
Cell Line
37%
Immune Response
33%
Fibronectin
33%
Human Papillomavirus Type 16
33%
Semliki Forest Virus
33%
Cell Interaction
33%
T-Helper Cell
33%
Cell Adhesion Molecule
29%
Cell Contact
29%
Gene Expression
25%
Mouse
25%
CD31
25%
Erythroleukemia Cell
25%
Binding Affinity
25%
E-Selectin
25%
Tumor Necrosis Factor Alpha
25%
Immunocompetent Cell
16%
Alphavirus
16%
interferon
16%
Survival Prediction
16%
Low Drug Dose
16%
CD44
12%
Extracellular Matrix
12%
Myeloid
12%
Leukemia Cell Line
12%
Epitope
8%
Fibroblast
8%
Tumor Cell Line
8%
Smooth Muscle
8%
CD29
8%
Actin
8%
